Naomi Kresge

Roche Holding AG said its third-quarter sales rose thanks to eye drug Vabysmo as well as medicines for cancer, hemophilia and multiple sclerosis.

By Madison Muller, Ashleigh Furlong and Naomi Kresge – Bloomberg Jennifer Witherspoon can't stop sharing photos of her new body.

Novartis AG boosted its annual profit guidance for the third straight quarter, helped by rising sales of its blockbuster medicines for psoriasis and cancer.

Novartis AG boosted its annual profit guidance for the third straight quarter, helped by rising sales of its blockbuster medicines for psoriasis and cancer.

Novartis AG's best-selling drug and a key new cancer medicine posted disappointing sales last quarter, even as the Swiss drugmaker lifted profit guidance for a third straight quarter.

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a red-hot market hinges on it.

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than some other next-generation contenders in the growing market for obesity drugs.

Novo Nordisk A/S’s sales of blockbuster weight-loss drug Wegovy beat expectations in the third quarter, a potential relief for investors after rival Eli Lilly & Co.’s disappointing obesity sales last week.

Novo Nordisk A/S's sales of the blockbuster weight-loss drug Wegovy leapt last quarter as it became available in more countries, a relief for investors after rival Eli Lilly & Co. reported disappointing obesity sales last week.

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, clearing a crucial early hurdle.